SRCIN1 Regulated by circCCDC66miR-211 Is Upregulated and Promotes Cell Proliferation in Non-Small-Cell Lung Cancer

Abstract EN

The incidence and mortality of lung cancer were extremely high.

The present study showed that SRCIN1 was an oncogene in non-small-cell lung cancer (NSCLC).

Public dataset analysis showed SRCIN1 was significantly overexpressed in NSCLC samples.

Also, we found that NSCLC patients with higher SRCIN1 expression had shorter OS time by analyzing TCGA, Kaplan-Meier Plotter, GSE30219, GSE50081, and GSE19188 databases.

Overexpression or knockdown of SRCIN1 significantly induced or reduced A549 and H1299 cell proliferation.

Furthermore, we found SRCIN1 was directly targeted by miR-211.

Overexpression or knockdown of miR-211 suppressed or induced SRCIN1 levels in NSCLC.

Moreover, we found that miR-211 affected NSCLC cell proliferation through SRCIN1.

Previous studies demonstrated that circRNAs could act as miRNA sponges in cancer cells.

In this study, we showed that knockdown of circCCDC66 induced expression of miR-211.

Luciferase assay demonstrated that miR-211 suppressed the activity of luciferase reporter-contained circCCDC66 sequences.

Moreover, knockdown of circCCDC66 significantly inhibited SRCIN1 levels in both A549 and H1299 cells.

These results showed that circCCDC66 acted as a miRNA sponge to affect the miR-211/SRCIN1 axis.

Of note, we for the first time revealed that circCCDC66 suppression reduced cell proliferation by about 65% in A549 and by about 40% in H1299 cells.

We thought this study could provide novel potential biomarkers for NSCLC.